Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × 4-fluorobenzoyl-TN-14003 × Clear all

NCT03154827 2024-09-05

Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)

Phase 1/2 Terminated

1 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute